Jinhe Pan

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

First-in-Human Evaluation of [68Ga]Ga-HTK03149, a PSMA-Targeted Tracer for PET Imaging in Prostate Cancer.

First-in-Human Evaluation of [68Ga]Ga-HTK03149, a PSMA-Targeted Tracer for PET Imaging in Prostate Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 26, 2025

Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation.

Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation.

Journal: Cancer letters
Published: March 30, 2020

H2CHXhox: Rigid Cyclohexane-Reinforced Nonmacrocyclic Chelating Ligand for [nat/67/68Ga]Ga3.

H2CHXhox: Rigid Cyclohexane-Reinforced Nonmacrocyclic Chelating Ligand for [nat/67/68Ga]Ga3.

Journal: Inorganic chemistry
Published: March 17, 2020

Pharmacokinetics, radiation dosimetry, acute toxicity and automated synthesis of [18F]AmBF3-TATE.

Pharmacokinetics, radiation dosimetry, acute toxicity and automated synthesis of [18F]AmBF3-TATE.

Journal: EJNMMI research
Published: December 30, 2019

H2hox: Dual-Channel Oxine-Derived Acyclic Chelating Ligand for 68Ga Radiopharmaceuticals.

H2hox: Dual-Channel Oxine-Derived Acyclic Chelating Ligand for 68Ga Radiopharmaceuticals.

Journal: Inorganic chemistry
Published: July 11, 2018

One-Step 18F-Labeling and Preclinical Evaluation of Prostate-Specific Membrane Antigen Trifluoroborate Probes for Cancer Imaging.

One-Step 18F-Labeling and Preclinical Evaluation of Prostate-Specific Membrane Antigen Trifluoroborate Probes for Cancer Imaging.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 26, 2018

Effects of Linker Modification on Tumor-to-Kidney Contrast of 68Ga-Labeled PSMA-Targeted Imaging Probes.

Effects of Linker Modification on Tumor-to-Kidney Contrast of 68Ga-Labeled PSMA-Targeted Imaging Probes.

Journal: Molecular pharmaceutics
Published: June 20, 2018

Radiolabeled R954 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography.

Radiolabeled R954 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography.

Journal: Molecular pharmaceutics
Published: January 18, 2017

Synthesis and evaluation of a 68Ga-labeled bradykinin B1 receptor agonist for imaging with positron emission tomography.

Synthesis and evaluation of a 68Ga-labeled bradykinin B1 receptor agonist for imaging with positron emission tomography.

Journal: Bioorganic & medicinal chemistry
Published: November 07, 2016

Targeting the Neuropeptide Y1 Receptor for Cancer Imaging by Positron Emission Tomography Using Novel Truncated Peptides.

Targeting the Neuropeptide Y1 Receptor for Cancer Imaging by Positron Emission Tomography Using Novel Truncated Peptides.

Journal: Molecular pharmaceutics
Published: September 27, 2016

2-18F-Fluoroethanol Is a PET Reporter of Solid Tumor Perfusion.

2-18F-Fluoroethanol Is a PET Reporter of Solid Tumor Perfusion.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 09, 2016

An imaging agent to detect androgen receptor and its active splice variants in prostate cancer.

An imaging agent to detect androgen receptor and its active splice variants in prostate cancer.

Journal: JCI insight
Published: August 16, 2016
Showing 1-12 of 27

Last Updated: 09/26/2026